20 filings
8-K
DSGN
Design Therapeutics Inc
19 Mar 24
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
DSGN
Design Therapeutics Inc
13 Nov 23
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
4:10pm
8-K
DSGN
Design Therapeutics Inc
25 Aug 23
Departure of Directors or Certain Officers
5:01pm
8-K
DSGN
Design Therapeutics Inc
14 Aug 23
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
4:07pm
8-K
DSGN
Design Therapeutics Inc
1 Jun 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
klskzh pzfig
9 May 23
Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
4:13pm
8-K
syj pyw4k
14 Mar 23
Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
4:07pm
8-K
mixodhp5 4eufnsgktd
3 Nov 22
Design Therapeutics Highlights Pipeline Progress and Upcoming Milestones and Reports Third Quarter 2022 Financial Results
4:09pm
8-K
wo0a55ottus 7tb
8 Aug 22
Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
4:08pm
8-K
onckl9s
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
utmo1ht
9 May 22
Design Therapeutics Highlights Clinical and Research Progress and Reports First Quarter 2022 Financial Results
4:09pm
8-K
8dz3cmkcewj49u
22 Mar 22
Entry into a Material Definitive Agreement
4:36pm
8-K
hg0ur si9rrut6oy21v
10 Mar 22
Design Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
4:06pm
8-K
j17qyyhoc5y
9 Nov 21
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
4:11pm
8-K
pmkoxi
20 Aug 21
Departure of Directors or Certain Officers
8:01am
8-K
941xf oxh
9 Aug 21
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
4:05pm
8-K
ltnsesnao2s557
6 Aug 21
Departure of Directors or Certain Officers
4:31pm
8-K
gok6b8 w4yesafcanl5n
7 Jun 21
Departure of Directors or Certain Officers
4:26pm
8-K
15nrf6951
10 May 21
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
4:10pm
8-K
v8uac51
30 Mar 21
Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:44pm
- Prev
- 1
- Next